Bruce Wendel

Exec. VP Corporate Development, APP Pharmaceuticals, Inc.

Companies

ImmunityBio, Inc.Board member Dec 16, 2025 to now¹
GT Biopharma, Inc.Board member Oct 7, 2021 to Feb 1, 2023²
Verastem OncologyBoard member Jun 16, 2016 to Jun 18, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

GT Biopharma, Inc. GTBP352,655 shares⁴$2.4M at $6.83Feb 16, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 16, 2021Granted 347,572 shares of GT Biopharma, Inc.⁴
Dec 22, 2020Bought 441 shares at $8.73 of GT Biopharma, Inc.⁴
Dec 22, 2020Bought 1,374 shares at $8.87 of GT Biopharma, Inc.⁴
Nov 16, 2020Bought 3,268 shares at $3.14 of GT Biopharma, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARImmunityBio, Inc., Board member
2
SEC EDGARGT Biopharma, Inc., Board member
3
SEC EDGARVerastem Oncology, Board member
4
SEC EDGARGT Biopharma, Inc. shares after the filing of Feb 16, 2021